Comparison of the Correlation Between Coagulation Indices and Rivaroxaban Concentrations
Annals of Pharmacotherapy · 2024-01 · 58 (1) · 28-36
DOI: 10.1177/10600280231158929 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Pharmacotherapy, online erschienen am 26.04.2023. Verfasst von Tingting Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Me…. Hauptthemen laut MEDLINE: Rivaroxaban, Thrombosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Background
Rivaroxaban has predictable pharmacokinetics and pharmacodynamics. However, monitoring rivaroxaban concentrations should be provided for special patients with hepatic insufficiency, high bleeding risk, and high thrombotic risk.
Objective
This study aimed to correlate chromogenic anti-Xa assay, prothrombin time (PT), activated partial thromboplastin time (APTT), thromboelastogram reaction time (TEG R-time), and rivaroxaban concentration measured by high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) (MS-Riva).
Methods
Peripheral venous blood was collected from recruited patients 30 minutes before and 2 to 4 hours after drug administration. High-performance liquid chromatography-tandem mass spectrometry and chromogenic anti-Xa assay measured rivaroxaban concentration. Different assays were compared by Pearson correlation coefficient and Bland-Altman analysis.
Results
A total of 104 patients with 191 plasma were included in the study. Overall analysis shows that chromogenic anti-Xa assay, PT, APTT, and TEG R-time strongly correlated with MS-Riva ( r = 0.986; r = 0.884; r = 0.741; r = 0.739; P < 0.001). Rivaroxaban peak concentration detected by HPLC-MS/MS (MS-peak) showed a very strong correlation with the chromogenic anti-Xa assay ( r = 0.977, P < 0.001) and moderate correlation with PT, APTT, and TEG R-time ( r = 0.670; r = 0.571; r = 0.481, P < 0.001). Rivaroxaban trough concentration detected by HPLC-MS/MS (MS-trough) correlated strongly with the chromogenic anti-Xa assay ( r = 0.884, P < 0.001), weakly with APTT ( r = 0.313; P = 0.043), and not significantly with PT and TEG R-time ( P = 0.140; P = 0.341). Conclusion and Relevance: High-performance liquid chromatography-tandem mass spectrometry/MS is the preferred choice for monitoring peak and tough concentrations, followed by anti-Xa, while PT is only suitable for peak concentrations. This study can help the clinicians to better adjust the medication regimen and reduce the risk of recurrence of thrombosis as well as the risk of bleeding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.
- Department of Pharmacy, First Hospital of Shanxi Medical University, Taiyuan, China.
ORCID-Profile: Jinhua Zhang
Zitieren
APA
Wu, T., Wu, S., Li, M., & Zhang, J. (2024). Comparison of the Correlation Between Coagulation Indices and Rivaroxaban Concentrations. Annals of Pharmacotherapy, 58(1), 28-36. https://doi.org/10.1177/10600280231158929
Vancouver
Wu T, Wu S, Li M, Zhang J. Comparison of the Correlation Between Coagulation Indices and Rivaroxaban Concentrations. Annals of Pharmacotherapy. 2024;58(1):28-36. doi:10.1177/10600280231158929
BibTeX
@article{Wu2024,
author = {Wu, Tingting and Wu, Shuyi and Li, Meijuan and Zhang, Jinhua},
title = {Comparison of the Correlation Between Coagulation Indices and Rivaroxaban Concentrations},
journal = {Annals of Pharmacotherapy},
year = {2024},
volume = {58},
number = {1},
pages = {28--36},
doi = {10.1177/10600280231158929}
}
EUVIMED